1. A matched case-control study of the prognosis of early breast cancer in patients with Li-Fraumeni syndrome (BREAST TP53). (April 2023) Authors: Petry, Vanessa; Bonadio, Renata Colombo; Testa, Laura; Cohn, Daniela JBH.; Cagnacci, Allyne; Campos, Roberta G.; Fragoso, Maria Cândida Bv; Estevez-Diz, Maria del Pilar Journal: Breast Issue: Volume 68(2023) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Issue 1 (January 2023) Authors: Johnston, Stephen R D; Toi, Masakazu; O'Shaughnessy, Joyce; Rastogi, Priya; Campone, Mario; Neven, Patrick; Huang, Chiun-Sheng; Huober, Jens; Jaliffe, Georgina Garnica; Cicin, Irfan; Tolaney, Sara M; Goetz, Matthew P; Rugo, Hope S; Senkus, Elzbieta; Testa, Laura; Del Mastro, Lucia; Shimizu, Chika... Journal: Lancet oncology Issue: Volume 24:Issue 1(2023) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant Treatment with 5‐Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer. (31st August 2020) Authors: Groehs, Raphaela V.; Negrao, Marcelo V.; Hajjar, Ludhmila A.; Jordão, Camila P.; Carvalho, Bruna P.; Toschi‐Dias, Edgar; Andrade, Ana C.; Hodas, Fabiana P.; Alves, Maria J.N.N.; Sarmento, Adriana O.; Testa, Laura; Hoff, Paulo M.G.; Negrao, Carlos E.; Filho, Roberto Kalil Journal: Oncologist Issue: Volume 25:Number 12(2020) Page Start: e1956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant Treatment with 5‐Fluorouracil and Oxaliplatin Does Not Influence Cardiac Function, Neurovascular Control, and Physical Capacity in Patients with Colon Cancer. (5th May 2021) Authors: Groehs, Raphaela V.; Negrao, Marcelo V.; Hajjar, Ludhmila A.; Jordão, Camila P.; Carvalho, Bruna P.; Toschi‐Dias, Edgar; Andrade, Ana C.; Hodas, Fabiana P.; Alves, Maria J.N.N.; Sarmento, Adriana O.; Testa, Laura; Hoff, Paulo M.G.; Negrao, Carlos E.; Filho, Roberto Kalil Journal: Oncologist Issue: Volume 26:Number 5(2021) Page Start: e907 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Breast cancer trends in women younger than 40 years in Brazil. (June 2022) Authors: Bonadio, Renata Colombo; Moreira, Otavio Augusto; Testa, Laura Journal: Cancer epidemiology Issue: Volume 78(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study. (December 2022) Authors: Oliveira, Leandro Jonata Carvalho; Megid, Thais Baccili Cury; Rosa, Daniela Dornelles; Magliano, Carlos Alberto da Silva; Assad, Daniele Xavier; Argolo, Daniel Fontes; Sanches, Solange Moraes; Testa, Laura; Bines, José; Kaliks, Rafael; Caleffi, Maira; de Melo Gagliato, Debora; Sahade, Marina; Bar... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective. (May 2022) Authors: Rosa, Daniela Dornelles; Magliano, Carlos Alberto da Silva; Simon, Sergio D.; Amorim, Gilberto; Reinert, Tomás; Landeiro, Luciana; Gagliato, Débora de Melo; Exman, Pedro; Argolo, Daniel; Guilgen, Gisah; Mano, Max; Testa, Laura; Liedke, Pedro; Barroso, Romualdo; Sasse, Mariana; Buehler, Anna Maria Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?. (November 2022) Authors: Bonadio, Renata Colombo; Tarantino, Paolo; Testa, Laura; Punie, Kevin; Pernas, Sonia; Barrios, Carlos; Curigliano, Giuseppe; Tolaney, Sara M.; Barroso-Sousa, Romualdo Journal: Cancer treatment reviews Issue: Volume 110(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial. Issue 4 (April 2021) Authors: Winer, Eric P; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Muñoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Zhou, Xuan; Karantza, Vassiliki;... Journal: Lancet oncology Issue: Volume 22:Issue 4(2021) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Return to work after breast cancer diagnosis: An observational prospective study in Brazil. Issue 24 (17th October 2018) Authors: Landeiro, Luciana C. G.; Gagliato, Debora M.; Fêde, Angelo B.; Fraile, Natalia M.; Lopez, Rossana M.; da Fonseca, Leonardo G.; Petry, Vanessa; Testa, Laura; Hoff, Paulo M.; Mano, Max S. Journal: Cancer Issue: Volume 124:Issue 24(2018) Page Start: 4700 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗